Egashira et al. found elevated CEA levels in five of 14 (35.7%) esophageal NEC cases, ranging from 5.3 to 19.6 ng/mL [20]. Thus, CEA elevation in NECs may be underrecognized. This evidence concerns the gene CEACAM5 and neuroendocrine carcinoma.